Estrogen-like chemical ups cancer risk in mice
Posted on: Tuesday, 12 July 2005, 15:08 CDT
NEW YORK (Reuters Health) - Exposure to the environmental estrogen 4-nonylphenol increases the risk of breast cancer in mice, a new study shows.
This research is another example demonstrating that estrogen-like chemicals in the environment "have the ability to cause cancer," Dr. William S. Baldwin from University of Texas at El Paso, El Paso, Texas told Reuters Health. "Whether they really do or not is unknown." The animals' exposure in this study was much higher than that encountered in the environment.
Breast cancer is the most commonly diagnosed cancer in women and environmental factors appear to cause many of these cases. Many of the environmental factors increase a woman's level of the female hormone estrogen, which is thought to be a major contributing factor to the disease.
In the Journal of Applied Toxicology, Baldwin and colleagues explain that 4-nonylphenol is released from cleaning agents, textiles, paper, plastic, personal care products and agricultural chemicals.
The team investigated the effects of 4-nonylphenol on the incidence of breast cancer in mice susceptible to the disease.
All five mice treated with 4-nonylphenol formed breast tumors, the researchers report, whereas one mouse in the control group and no mice treated with the female hormone estradiol formed breast tumors.
Treatment with 4-nonylphenol also shortened the latency period before mammary tumor development and increased the likelihood that breast tumors would spread to the lung.
Baldwin cautioned that the doses of 4-nonylphenol given to the mice are "much greater than what humans are exposed to on a daily basis." He estimated the dose at 1000 times the level of human exposure.
Baldwin and his colleagues plan to continue their investigations by looking into the effects of developmental exposures of nonylphenol on breast cancer.
SOURCE: Journal of Applied Toxicology July/August 2005.
Source: REUTERS
Related Articles
- More Women Choosing To Remove Healthy Breast After Cancer Diagnosis
- Skin Cancer Study Shows New Tumor Suppressor Gene
- Join NPR's David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
- New Drug Combination is Able to Eradicate Breast Metastases in Mice
- The Report Will Not Only Provide A Framework But Also A Careful Identification And Evaluation Of Breast Prostate Cancer Drug Candidates, Technologies And Competitors
- Hana Biosciences Presents Positive Preclinical Data for Three Anti-Cancer Product Candidates At the AACR-NCI-EORTC International Conference; Optisomal Formulations of Vincristine, Vinorelbine and Topotecan Demonstrate Prolonged Tumor Exposure, Improved T
- Breast-Ovarian Cancer Syndrome Ups Risk
- FDA Grants Intracel Special Protocol Assessment (SPA) for Confirmatory, Pivotal Phase III Study of OncoVAX(R) Colon Cancer Vaccine; OncoVAX(R) Vaccine Designed to Prevent Recurrence in Stage II Colon Cancer Patients Following Surgical Tumor Resection
- New Data From the Women's Health Initiative Study Show No Increased Risk of Breast Cancer With Conjugated Estrogens Alone
- Key Protein in Breast, Ovarian Cancer Found
 |
 |
User Comments (0)
RSS Feeds